Ionis Pharmaceuticals, Inc. (IONS)

SEC filing

Ionis Pharmaceuticals, Inc.

IONS · CIK 874015

4 · Oct 19, 2026 · EVP Research Swayze Eric sold 53 shares at $43.54/share ($2,308); exercised options for 250 shares

EVP Research Swayze Eric sold 53 shares at $43.54/share ($2,308); exercised options for 250 shares

PRIMARY DOCUMENT

xslF345X06/edgardoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).